Real-World Outcomes of Patients with Resectable Early-Stage Non-Small Cell Lung Cancer Treated with Neoadjuvant Chemoimmunotherapy

被引：0
|
作者：
Hazim, A. [1 ]
Xiao, A. [1 ]
Singh, A. [1 ]
Chung, K. [2 ]
dos Santos, P. A. Reck [2 ]
D'Cunha, J. [2 ]
Shanshal, M. [1 ]
Dimou, A. [1 ]
Parikh, K. [1 ]
Lou, Y. [3 ]
Manochakian, R. [3 ]
Leventakos, K. [1 ]
Molina, J. [1 ]
Mansfield, A. [1 ]
Ernani, V. [2 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Scottsdale, AZ USA
[3] Mayo Clin, Jacksonville, FL 32224 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
chemoimmunotherapy; neoadjuvant; non small cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.07C.16
引用
收藏
页码：S546 / S547
页数：2
相关论文
共 50 条
  • [31] Neoadjuvant and Adjuvant Immunotherapy: Opening New Horizons for Patients With Early-Stage Non-small Cell Lung Cancer
    Bai, Rilan
    Li, Lingyu
    Chen, Xiao
    Chen, Naifei
    Song, Wei
    Cui, Jiuwei
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [32] Features of fatigue in patients with early-stage non-small cell lung cancer
    Huang, Xianping
    Zhou, Weihe
    Zhang, Yuefeng
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2015, 20 (03): : 268 - 272
  • [33] Trends and Outcomes of Salvage Lobectomy for Early-stage Non-Small Cell Lung Cancer
    Afshari, Sam
    Anker, Christopher J.
    Kooperkamp, Hannah Z.
    Sprague, Brian L.
    Lester-Coll, Nataniel H.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2023, 46 (06): : 271 - 275
  • [34] Real-World Data on Patients With Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiotherapy (SBRT)
    Van der Woude, L.
    Van der Wel, A.
    Van Bockel, L.
    Coremans, I.
    Dekker, A.
    Van Es, C.
    De Jaeger, K.
    Knol, H. P.
    Kolff, W.
    Koppe, F.
    Pomp, J.
    Schinagl, D.
    Spoelstra, F.
    Tissing-Tan, C.
    Ubbels, F.
    Vonk, E.
    Van der Voort-Van Zijp, N.
    Wiegman, E.
    Van der Geest, A.
    Reymen, B.
    Van Kampen, D.
    Damhuis, R.
    Belderbos, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S269 - S270
  • [35] Real-world Disease-Free Survival as a Predictor of Overall Survival in Resected Early-Stage Non-Small Cell Lung Cancer
    West, H.
    Hu, X.
    Chirovsky, D.
    Song, Y.
    Zhang, S.
    Gao, C.
    Carley, C.
    Lerner, A.
    Signorovitch, J.
    Samkari, A.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S219 - S220
  • [36] Neoadjuvant immunotherapy for resectable non-small cell lung cancer
    Xie, Hui
    Shi, Xuejun
    Wang, Guangshun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (06): : 2521 - 2536
  • [37] Neoadjuvant Pembrolizumab for Early Stage Non-Small Cell Lung Cancer
    Bar, J.
    Urban, D.
    Redinsky, I.
    Ackerstein, A.
    Daher, S.
    Kamer, I.
    Onn, A.
    Shulimzon, T.
    Peled, M.
    Zeitlin, N.
    Kremer, R.
    Raskin, S.
    Ben-Nun, A.
    Perelman, M.
    Ofek, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S865 - S866
  • [38] Neoadjuvant chemotherapy for early stage non-small cell lung cancer
    Beitler, AL
    Urschel, JD
    Takita, H
    MEDICAL SCIENCE RESEARCH, 1998, 26 (12): : 853 - 854
  • [39] Neoadjuvant Immune Checkpoint Inhibitor plus Chemotherapy for Resectable Non-small Cell Lung Cancer in Real World
    Chen, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S579 - S580
  • [40] Immune checkpoint inhibition in early-stage non-small cell lung cancer
    Cuppens, Kristof
    Du Pont, Bert
    Knegjens, Joost
    Maes, Brigitte
    Baas, Paul
    LUNG CANCER, 2024, 193
12345